Immunohistochemical signaling pathways of triple negative and triple positive breast cancers: What is new?-Reference-Cited by-同舟云学术

Immunohistochemical signaling pathways of triple negative and triple positive breast cancers: What is new?

Published:2021-12 Issue: Volume:55 Page:151831
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Elsers Dalia A.,Masoud Eman Mostafa,Kamel Nermeen A.M.H.,Ahmed Asmaa M.

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference28 articles.

1. Androgen receptor in breastcancer:frombench to bedside;Chen;Front Endocrinol (Lausanne),2020

2. Breast cancer in women aging 35 years old and younger: theegyptian National Cancer Institute (NCI) experience;Darwish;Breast,2017

3. Androgen receptor in breastcancer-clinical and preclinicalresearchinsights;Anestis;Molecules,2020

4. Comparative study for clinicaloutcomes of triple-positive and triple-negativebreastcancer:long-termresults in 161 patientsfollowed in a singlecenter;Baeg,2020

5. Triple-negative breast cancer: pretreatment magnetic resonance imaging features and clinicopathological factors associated with recurrence;Lee;Magn Reson Imaging,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of GATA3 expression in triple-positive breast cancer with overall survival and immune cell infiltration;Scientific Reports;2024-08-01

2. Androgen Receptor interacts with c-Myc to regulate macrophage-osteoclast axis and drive bone metastasis in Triple Negative Breast Cancer;2024-05-02

3. The Role of the Tumor Microenvironment in Triple-Positive Breast Cancer Progression and Therapeutic Resistance;Cancers;2023-11-20

4. Biomarkers derived from CmP signal network in triple negative breast cancers;Translational Breast Cancer Research;2023-07